Care | ToriNews.com

Now that you have arrived from the hospital with your baby, there might be numerous apprehensions and anxieties mounting your mind. This is one common thing as most of the new moms meddle hard to acquire answers of newborn care questions. With things becoming accessible via web one can even go in for online pediatric advice as this can make those complicated things go simple. Now that the nurses and doctors gone, mothers need to take the control of their kids health in their hand and assure that they do all that the kid requires.

It has been found that most of the new born babies are prone to diseases such as jaundice and skin care issues, but it really does not mean that these cannot be avoided. During the early days the parents need to ensure that the kid stays in the required temperature and mother’s body also retains the same one as this can seize the occurrence of jaundice and other diseases. Marks and skin rashes also tend to give new moms a tough time and one need to know that in such situations nothing much effectual baby body oil has to be taken.

If the baby appears to cry often or is behaving in an irritable manner, then this is the warning sign that the kids health is not fine and it needs immediate attention. If the baby’s digestive system is appearing changed or if the baby is vomiting, then an effective and timely online pediatric advice can be of great help. There are many new born babies who feel difficult to breathe during initial days or suffer from congestion. In this case, it would be better to stop giving the baby any cold food items and visit the pediatrician soon.

Newborn baby requires loads of nutrition, but one needs to know the amount and the form in which this has to be provided. If the baby is on breast milk then he or she is surely getting the required nutrition and no supplements such as juice, water and cereals are required. Newborn health screening on regular intervals makes the parents know that the kid is healthy. During the screening session, most of the parents are advised to ask maximum possible newborn care questions from the pediatrician such as is the baby suffering from any deficiency, is the baby prone to any allergies and what the overall health score is.

Once answers to all these questions are acquired, one can be rest assured that the new born is enjoying an overall good health. Parents who feel that they don’t have the time to visit the pediatrician again and again can follow the route of online pediatrician advice.

Retrieved from “http://www.articlesbase.com/health-articles/newborn-care-questions-can-bring-an-end-to-those-apprehensions-3721569.html”

(ArticlesBase SC #3721569)

Watch your traffic increase just by submitting articles with us, click here to get started.
Liked this article? Click here to publish it on your website or blog, it’s free and easy!

gregg -
About the Author:

For more information on online pediatrician advice and newborn care questions , Please visit http://www.globalpediatrician.com/

Questions and Answers

Ask our experts your Health related questions here…

Ask

200 Characters left

Health and social care questions about growth and develpoment. like what age did you start to walk ?
What do open ended questions start with ?
What are some good open ended questions ?

Rate this Article

1
2
3
4
5

vote(s)
0 vote(s)

Feedback
RSS
Print
Email
Re-Publish

Source: http://www.articlesbase.com/health-articles/newborn-care-questions-can-bring-an-end-to-those-apprehensions-3721569.html

Article Tags:
online pediatrician advice

Safetox – an Anti Ageing Skin Care Device to Look Younger and Radiant

Posted on 03 October 2010. Tags: Ageing, Anti, Care, Device, Look, Radiant, Safetox, Skin, Younger

Safetox – an Anti Ageing Skin Care Device to Look Younger and Radiant

Safetox is a revolutionary new electronic device that promises to make you look younger by easing wrinkles on your face, without injection or surgery. Safetox has been highly appreciated in the media as the safest and most effective way to defy the signs of ageing. Just two sessions of Safetox lasting for about 5 minutes each, produce a reduction in wrinkles to up to 11%. After 6 weeks of use, you will be stunned to notice a new you as Safetox will reduce wrinkles to approximately 65%.

How Safetox works?

Our face is constantly active. There are several muscles underneath the skin whose movements determine its general aspect and facial expressions. These facial muscles are also responsible for the fine or prominent wrinkles that appear on the epidermis. Safetox uses advanced technology to ease wrinkles on your face. Its special formula differentiates between âgoodâ posterior muscles that open up the face and âbadâ muscles in the central and upper part of the face that close up the face. While the good muscles give the face an active facelift effect, the bad muscles cause wrinkles to appear and can even lead to headaches. Tiredness, stress and arguing make their impact even more pronounced. Safetox inhibits the âbadâ muscles that cause wrinkles and stimulates the âgoodâ muscles that open up the face and lift the skin.

Using an advanced electro-inhibition mechanism pain-free electronic impulses are sent to the target muscles using an adhesive patch. These impulses inhibit the âbadâ muscles in the central and upper part of the face (pyramidal, eyebrow and frontal). The very specific impulses are set up in such a way as to temporarily suppress the excitability of the target muscles. This state of in-excitability leads to a state of deep relaxation and eliminates tone in the muscle fibers targeted. At the same time the positive muscles, found at the rear of the head and above the ears, are stimulated helping to ‘open’ the face.

Benefits of Safetox on skin care

Safetox anti-wrinkle device is easy to use and comes with a host of benefits -

Developed after a vast amount of research, Safetox is an effective skincare product with no side-effects.

Just a few sessions using Safetox will give better skin results than months of treatment with the best quality creams.

Two sessions of Safetox produce a reduction in wrinkles of around 11% is obtained, rising to approximately 65% after 6 weeks.

With regular use, this active facelift effect educates the muscles of the face, creating a more youthful and radiant complexion in just 4 weeks.

Unlike other facial care procedures anyone can use Safetox on their own, without intervention of a beautician or a doctor.

Safetox helps you save a lot of money in the long run. It works on cheaper than spending money on a host of expensive anti-wrinkle lotions and potions.

Rozane writes articles on Beauty issues relating to health. Among her many written articles are Safetox â an anti wrinkle treatment.

Find More New Electronic Devices Articles
The Ensemble Is An Electronic Device, New Music

US $7.98
End Date: Wednesday Feb-08-2012 18:23:37 PST
Buy It Now for only: US $7.98
Buy it now | Add to watch list

Posted in COMPUTING & INTERNETComments (0)

Kids health care plans on hold in Missouri

Posted on 14 August 2010. Tags: Care, HEALTH, hold, Kids, Missouri, plans

by Christiana Care

Kids health care plans on hold in Missouri

It’s known as “Express Lane Eligibility” â an effort to put children on the fast track for government-run health care coverage.

But in Missouri, the Express Lane has become the slow lane.Â Â Â Â Â Â Documents obtained by The Associated Press show the Missouri Department of Social Services recommended the adoption this spring of a half-dozen measures intended to enroll more children in government health care programs for low- and middle-income families.

With winter now approaching, none of those recommendations has been implemented.

“It takes money to do it,” Gov. Jay Nixon explained last week. “With the downturn in the economy, we just have not had the resources to expand that area.”

The expansion of health coverage was one of Nixon’s chief campaign pledges last year. It will remain unfulfilled as he ends his first year as governor.

The Republican-led Legislature rejected the Democratic governor’s proposals earlier this year to add more low-income adults to Medicaid and to expand the Children’s Health Insurance Program by eliminating or lowering the premiums charged to families.

But when President Barack Obama signed legislation in early February giving states new ways to more easily enroll children in government health care programs, Nixon’s administration quickly began working behind the scenes to take advantage of its provisions.

Within weeks, a top official in the Family Services Division of Missouri’s social services agency had identified Express Lane Eligibility as “our best bet for rapidly increasing enrollment” in Missouri’s health care programs, according to documents provided last week to the AP in response to an October open-records request.

Express Lane Eligibility allows states to assume that children already enrolled in other federal aid programs such as food stamps or child care also are eligible to receive health coverage under Medicaid or the Children’s Health Insurance Program.

A March 26 department memo identified the sped-up eligibility effort as one of a half dozen options â labeled “Recommendation: PROCEED” â to increase enrollment in Medicaid and the Children’s Health Insurance Program. To do everything would have cost the state more than million. The result would have been nearly 42,000 additional people â mainly children â covered by Missouri’s health care programs.

On Feb. 26 and again on April 16, Department of Social Services officials met with children’s health care advocates to discuss options for expanding enrollment in health care programs. Following the second meeting, department director Ron Levy sent a memo to Nixon’s staff indicating a strong consensus to “move forward on the express lane eligibility.”

By the end of April, department staff had begun running computer tests to identify children enrolled in other aid programs who could be eligible for Medicaid. They also had developed a form letter to be mailed to thousands of parents.

But the enrollment letters never were sent.

Around that time, Missouri’s tax revenues took a sharp turn for the worse. Nixon began the new fiscal year July 1 by announcing 0 million of budget vetoes and spending cuts.

Nonetheless, advocacy groups turned up the pressure on Nixon. They sent a letter signed by more than 50 individuals and groups urging him to direct the Department of Social Services to implement five specific steps to insure more children.

The timing couldn’t have been worse.

The mid-July advocacy letter arrived the same week that the Department of Social Services warned Nixon’s budget office that the Medicaid program likely would need an additional million in state funds to avoid a shortfall during the 2010 fiscal year. One main reason: an expected enrollment increase of 37,000 children due to the poor economy. The department said there likely was some overlap between the newly enrolled children and those who would have been reached by the Express Lane Eligibility program.

But that hasn’t made it easier for Nixon’s administration to explain to advocates why it hasn’t been able to follow through on Nixon’s promise to expand health coverage for children.

“We’re getting the crap beat out of us for not moving forward now on express lane enrollment … which we need to do!” department director Levy wrote to his Medicaid division director, Ian McCaslin, on July 30.

Department spokesman Scott Rowson said Friday that the agency still wants to implement Express Lane Eligibility and other efforts to enroll more children in government health coverage. But he acknowledged: “It’s probably not likely in the 2010 fiscal year,” which runs through June 30.

Nixon also said he still supports efforts to expand government health coverage for children and the working poor. The governor said he’s watching what becomes of the health care debate in Washington and monitoring the state’s bank accounts.

“If we get an uptick and we have the resources to do it, you can rest well assured we’ll be prepared to do it,” Nixon said.

Quoting & Saving just got easier…EasyToInsureME Health Insurance Quotes… Quote all carriers in seconds

Missouri Health Insurance
Arkansas Health Insurance

101 Kid Summer Activities
Discover How to Make Magical Moments This Summer With Your Kids!
101 Kid Summer Activities

See Pharma funds behind Mental “screening” www.signsofsuicide.org and visit www.cchrint.org – Mental health screening is a tool of the psycho industry used as a feeder line to get more kids and adults on drugs. Depression Screening Day was created by Signs Of Suicide, a group receiving millions in Pharma funding. Click on link above for the documents. Find out more: www.cchr.org http www.teenscreentruth.com

Kids health care plans on hold in Missouri

Posted on 27 July 2010. Tags: Care, HEALTH, hold, Kids, Missouri, plans

by KellyB.

Kids health care plans on hold in Missouri

It’s known as “Express Lane Eligibility” — an effort to put children on the fast track for government-run health care coverage.

But in Missouri, the Express Lane has become the slow lane.

Documents obtained by The Associated Press show the Missouri Department of Social Services recommended the adoption this spring of a half-dozen measures intended to enroll more children in government health care programs for low- and middle-income families.

With winter now approaching, none of those recommendations has been implemented.

“It takes money to do it,” Gov. Jay Nixon explained last week. “With the downturn in the economy, we just have not had the resources to expand that area.”

The expansion of health coverage was one of Nixon’s chief campaign pledges last year. It will remain unfulfilled as he ends his first year as governor.

The Republican-led Legislature rejected the Democratic governor’s proposals earlier this year to add more low-income adults to Medicaid and to expand the Children’s Health Insurance Program by eliminating or lowering the premiums charged to families.

But when President Barack Obama signed legislation in early February giving states new ways to more easily enroll children in government health care programs, Nixon’s administration quickly began working behind the scenes to take advantage of its provisions.

Within weeks, a top official in the Family Services Division of Missouri’s social services agency had identified Express Lane Eligibility as “our best bet for rapidly increasing enrollment” in Missouri’s health care programs, according to documents provided last week to the AP in response to an October open-records request.

Express Lane Eligibility allows states to assume that children already enrolled in other federal aid programs such as food stamps or child care also are eligible to receive health coverage under Medicaid or the Children’s Health Insurance Program.

A March 26 department memo identified the sped-up eligibility effort as one of a half dozen options — labeled “Recommendation: PROCEED” — to increase enrollment in Medicaid and the Children’s Health Insurance Program. To do everything would have cost the state more than million. The result would have been nearly 42,000 additional people — mainly children — covered by Missouri’s health care programs.

On Feb. 26 and again on April 16, Department of Social Services officials met with children’s health care advocates to discuss options for expanding enrollment in health care programs. Following the second meeting, department director Ron Levy sent a memo to Nixon’s staff indicating a strong consensus to “move forward on the express lane eligibility.”

By the end of April, department staff had begun running computer tests to identify children enrolled in other aid programs who could be eligible for Medicaid. They also had developed a form letter to be mailed to thousands of parents.

But the enrollment letters never were sent.

Around that time, Missouri’s tax revenues took a sharp turn for the worse. Nixon began the new fiscal year July 1 by announcing 0 million of budget vetoes and spending cuts.

Nonetheless, advocacy groups turned up the pressure on Nixon. They sent a letter signed by more than 50 individuals and groups urging him to direct the Department of Social Services to implement five specific steps to insure more children.

The timing couldn’t have been worse.

The mid-July advocacy letter arrived the same week that the Department of Social Services warned Nixon’s budget office that the Medicaid program likely would need an additional million in state funds to avoid a shortfall during the 2010 fiscal year. One main reason: an expected enrollment increase of 37,000 children due to the poor economy. The department said there likely was some overlap between the newly enrolled children and those who would have been reached by the Express Lane Eligibility program.

But that hasn’t made it easier for Nixon’s administration to explain to advocates why it hasn’t been able to follow through on Nixon’s promise to expand health coverage for children.

“We’re getting the crap beat out of us for not moving forward now on express lane enrollment … which we need to do!” department director Levy wrote to his Medicaid division director, Ian McCaslin, on July 30.

Department spokesman Scott Rowson said Friday that the agency still wants to implement Express Lane Eligibility and other efforts to enroll more children in government health coverage. But he acknowledged: “It’s probably not likely in the 2010 fiscal year,” which runs through June 30.

Nixon also said he still supports efforts to expand government health coverage for children and the working poor. The governor said he’s watching what becomes of the health care debate in Washington and monitoring the state’s bank accounts.

“If we get an uptick and we have the resources to do it, you can rest well assured we’ll be prepared to do it,” Nixon said.

Quoting & Saving just got easier…EasyToInsureME Health Insurance Quotes… Quote all carriers in seconds

Missouri Health Insurance
Arkansas Health Insurance

Little Kid Crafts For All Seasons
Discover Quick and Easy Crafts Guaranteed To Spark Your Child’s Imagination and Thirst for Learning and Create Lots of Family Fun!
Little Kid Crafts For All Seasons

The Future Of The Diabetes Care Devices Market To 2016 – The Key Demand Drivers Remain Intact

Posted on 24 June 2010. Tags: 2016, Care, Demand, Devices, Diabetes, Drivers, Future, Intact, Market, Remain

The Future Of The Diabetes Care Devices Market To 2016 – The Key Demand Drivers Remain Intact

GBI Research’s new report, “The Future of the Diabetes Care Devices Market to 2016 – The Key Demand Drivers Remain Intact” provides key data, information and analysis on the global diabetes care devices market, a key segment within the medical equipment industry. This medical device report provides market landscape, competitive landscape and market trends information on two diabetes care devices market categories – glucose monitoring and insulin delivery. The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the competitive landscape, key pipeline products and technology offerings. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Scope
• Key geographies including the US (United States), Canada, the UK (United Kingdom), Germany, France, Italy, Spain, Japan, China, India, Australia and Brazil.
• Global Market size and company share data for three diabetes care devices market categories – glucose monitoring and insulin delivery.
• Annualized market revenues data from 2002 to 2009, forecast forward for 7 years to 2016. Company shares data for 2008.
• Qualitative analysis of key market trends, market drivers and restraints by categories and segments.
• Competitive landscape and key company profiles. Key players covered include Roche, LifeScan, Bayer, Abbott, Becton, Dickinson, Medtronic, Novo Nordisk, Sanofi-Aventis, Eli Lilly, ARKRAY, Terumo, Animas and Smiths Medical.
• Key in-pipeline products and technologies expected to hit the global diabetes care devices market in the near future.

Reasons to buy
• Develop business strategies by understanding the trends and developments that are driving the diabetes care devices market globally.
• Design and develop your product development, marketing and sales strategies.
• Exploit M&A opportunities by identifying market players with the most innovative pipeline.
• Develop market-entry and market expansion strategies.
• Identify key players best positioned to take advantage of the emerging market opportunities.
• Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
• What’s the next big thing in the diabetes care devices market landscape? – Identify, understand and capitalize.
• Make more informed business decisions from the insightful and in-depth analysis of the diabetes care devices market and the factors shaping it.

1 Table of Contents

1.1 List of Tables 7
1.2 List of Figures 9

2 Introduction and Overview 11
2.1 Type 1 Diabetes 11
2.2 Type 2 Diabetes 11
2.3 Diabetes Accentuating Cardiovascular Disease 11
2.3.1 Atherosclerosis 11
2.3.2 Diabetic Cardiomyopathy 11
2.3.3 Stroke 11
2.3.4 Renal Disease 12
2.4 Diabetes a Burden on Healthcare Spending 12
2.5 Prevalence and Incidence of Diabetes 12
2.5.1 Global 12
2.5.2 Diabetes Prevalence in Developing Nations 13

3 Diabetes Care Devices Market: Market Characterization 14
3.1 Global Diabetes Care Devices Market, Revenues ($m), 2002 – 2009 14
3.2 Global Diabetes Care Devices Market, Revenue Forecasts ($m), 2009 – 2016 15
3.3 Diabetes Care Devices, Key Market Trends 15
3.3.1 Home Healthcare Driving Growth in the Diabetes Care Devices Market 15
3.3.2 Brand Loyalty in Diabetes Care Devices: Hard To Achieve 16
3.3.3 Reimbursement Issues Restraining the Market 16
3.3.4 Drug Stores to Remain the Major Distribution Channels 16
3.4 Diabetes Care Devices: Technological Trends 17
3.4.1 Enhancing Life 17
3.4.2 Continuous Glucose Monitoring (CGM) 18
3.4.3 Disposable Insulin Pumps 18
3.4.4 Pain Free Monitoring Devices Will Drive Future Growth in the Diabetes Care Device Market 20
3.4.5 Increasing Demand for Pain Free Insulin Delivery Devices 21
3.4.6 Remote Monitoring: Increasing Diabetic Compliance 21
3.5 Diabetes Care Devices, Market Drivers 22
3.5.1 New Technologies to Boost Sales 22
3.5.2 Increasing Prevalence of Diabetes to Boost Sales 23
3.5.3 The Increasing Ageing Population of the World to Increase Patient Population 25
3.5.4 Introduction of New Generation Devices to Drive the Glucose Monitoring Market 25
3.5.5 Increase in Awareness of Better Diabetes Management 26
3.5.6 Lifestyle Changes Bringing About the Increase in Disease Prevalence 26
3.5.7 Product Innovation to Increase Acceptance 26
3.6 Restraints 26
3.6.1 Lack of Affordability and Awareness in Developing Nations 26
3.6.2 Lack of Reimbursement for New Technologies 26
3.6.3 Low diagnosis rate 26
3.6.4 Low Patient Compliance 27
3.6.5 Overall Cost Is a Restraint for Insulin Pens And Pumps 27
3.6.6 Other Factors Restraining the Diabetes Care Devices Market 27
3.6.7 Low Market Penetration Affecting Growth 27
3.7 Global Diabetes Care Devices Market, Key Company Shares (%), 2008 28

4 Global Diabetes Care Devices Market: Cross-Segment Market Analysis and Forecasts 29
4.1 Glucose Monitoring Market 29
4.1.1 Global Glucose Monitoring Market, Revenues ($m), 2002 – 2009 29
4.1.2 Global Glucose Monitoring Market, Revenue Forecasts ($m), 2009 – 2016 30
4.1.3 Market Drivers 30
4.1.4 Market Restraints 31
4.1.5 Glucose Monitoring Market, Revenue by Segment 32
4.1.6 Blood Glucose Meters Market Dynamics 33
4.1.7 Blood Glucose Test Strips Market Revenue 34
4.1.8 Blood Glucose Test Strips Market Dynamics 35
4.2 Insulin Delivery Devices 36
4.2.1 Global Insulin Delivery, Revenue ($m), Global, 2002 – 2009 37
4.2.2 Global Insulin Delivery, Revenue ($m), Global, 2009 – 2016 38
4.2.3 Market Drivers 38
4.2.4 Market Restraints 39
4.2.5 Insulin Pumps Market Revenue 40
4.2.6 Insulin Pumps, Revenue ($m), Global, Forecast 41
4.2.7 Insulin Pumps Market Dynamics 41
4.2.8 Insulin Pens Market Revenue 42
4.2.9 Insulin Pens Market Dynamics 44
4.2.10 Insulin Syringes, Market Revenue 44
4.2.11 Insulin Syringes Market Dynamics 45

5 Diabetes Care Devices: Competitive Landscape 46
5.1 Insulin Delivery Competitive Landscape 46
5.1.1 Strategic Competitor Assessment 46
5.1.2 Insulin Delivery Devices, Company Share Analysis (%), 2008 47
5.2 Key Companies 47
5.2.1 Becton, Dickinson and Company 47
5.2.2 Medtronic 47
5.2.3 Novo Nordisk 47
5.2.4 Others 48
5.2.5 Insulet Corporation 48
5.2.6 NiliMEDIX 48
5.2.7 Medingo Ltd. 48
5.2.8 Debiotech S.A 48
5.2.9 Phluid Corporation 48
5.2.10 Ratio Inc. 48
5.2.11 Insuline Medical Ltd. 48
5.2.12 Aradigm Corporation 48
5.2.13 MannKind Corporation 49
5.2.14 Altea Therapeutics Corporation 49
5.3 Glucose Monitoring Systems Market : Competitive Assessment 49
5.3.1 Overview 49
5.3.2 Strategic Competitor Assessment 49
5.3.3 Glucose Monitoring Systems Company Shares 2008 50
5.3.4 F. Hoffmann-La Roche Ltd 50
5.3.5 LifeScan (Johnson & Johnson) 51
5.3.6 Bayer Healthcare 51
5.3.7 Abbott Laboratories 51
5.3.8 Product Profiles of the Major Marketed Products in the Glucose Monitoring Systems Market 52
5.3.9 OneTouch UltraMini 53
5.3.10 Contour Meter 54

6 Global Diabetes Care Devices Market: Cross-Country Analysis and Forecasts 55
6.1 Revenues, By Country, 2002 – 2009 55
6.1.1 The US Diabetes Care Devices Market, Revenue ($m), 2002 – 2009 55
6.1.2 Canada Diabetes Care Devices Market, Revenues ($m), 2002 – 2009 56
6.1.3 The UK Diabetes Care Devices Market, Revenues ($m), 2002 – 2009 57
6.1.4 Germany Diabetes Care Devices Market, Revenues ($m), 2002 – 2009 58
6.1.5 France Diabetes Care Devices Market, Revenues ($m), 2002 – 2009 59
6.1.6 Italy Diabetes Care Devices Market, Revenues ($m), 2002 – 2009 60
6.1.7 Spain Diabetes Care Devices Market, Revenues ($m), 2002 – 2009 61
6.1.8 Japan Diabetes Care Devices Market, Revenues ($m), 2002 – 2009 62
6.1.9 China Diabetes Care Devices Market, Revenues ($m), 2002 – 2009 63
6.1.10 India Diabetes Care Devices Market, Revenues ($m), 2002 – 2009 64
6.1.11 Australia Diabetes Care Devices Market, Revenues ($m), 2002 – 2009 65
6.1.12 Brazil Diabetes Care Devices Market, Revenues ($m), 2002 – 2009 66
6.2 Revenue Forecasts, By Country, 2009 – 2016 67
6.2.1 The US Diabetes Care Devices Market, Revenues ($m), 2009 – 2016 67
6.2.2 Canada Diabetes Care Devices Market, Revenues ($m), 2009 – 2016 68
6.2.3 The UK Diabetes Care Devices Market, Revenues ($m), 2009 – 2016 69
6.2.4 Germany Diabetes Care Devices Market, Revenues ($m), 2009 – 2016 70
6.2.5 France Diabetes Care Devices Market, Revenues ($m), 2009 – 2016 71
6.2.6 Italy Diabetes Care Devices Market, Revenues ($m), 2009 – 2016 72
6.2.7 Spain Diabetes Care Devices Market, Revenues ($m), 2009 – 2016 73
6.2.8 Japan Diabetes Care Devices Market, Revenues ($m), 2009 – 2016 74
6.2.9 China Diabetes Care Devices Market, Revenues ($m), 2009 – 2016 75
6.2.10 India Diabetes Care Devices Market, Revenues ($m), 2009 – 2016 76
6.2.11 Australia Diabetes Care Devices Market, Revenues ($m), 2009 – 2016 77
6.2.12 Brazil Diabetes Care Devices Market, Revenues ($m), 2009 – 2016 78

7 Diabetes Care Devices: Pipeline Analysis 79
7.1 Glucose Monitoring Key Pipeline Products 79
7.1.1 Strategic Pipeline Assessment 79
7.1.2 Glucose Monitoring Systems – Pipeline by Clinical Phase of Development 80
7.1.3 Profiles of Promising Devices under Clinical Development 80
7.1.4 Glucose Monitoring Systems Market: List of Pipeline Products 83
7.1.5 Glucose Monitoring Systems Pipeline Product Summary by Product Type 86
7.1.6 Glucose Monitoring Systems Pipeline Product Summary: Home Glucose Monitoring Systems 87
7.1.7 Glucose Monitoring Systems Pipeline Product Summary: Hospital Setting Glucose Monitoring Systems 89
7.1.8 Glucose Monitoring Systems Pipeline Product Summary: Both Home and Hospital Setting Glucose Monitoring Systems 89
7.2 Implications for Future Market Competition 90
7.3 Strategic Competitor Assessment 90
7.4 Glucose Monitoring Systems Market: Emerging Companies 91
7.4.1 Introduction 91
7.5 Insulin Delivery Key Pipeline Products 92
7.5.1 Overview 92
7.5.2 Strategic Pipeline Assessment 93
7.5.3 Insulin Delivery Devices – Clinical Pipeline by Mode of Insulin Delivery 94
7.6 Insulin Delivery Devices – Pipeline by Clinical Phase of Development 95
7.7 Insulin Delivery Devices Pipeline Product Summary 96
7.8 Insulin Delivery Devices – Promising Devices under Clinical Development 96
7.8.1 Closed-loop diabetes management system 96
7.8.2 Paradigm Veo System 97
7.8.3 AERx insulin Diabetes Management System 98
7.8.4 Insulin Delivery Devices – Future Market Competition 102
7.8.5 Strategic Competitor Assessment 102
7.9 Reimbursement for Insulin Delivery Devices 103

8 Global Diabetes Care Devices Market: Consolidation Landscape 105
8.1 Deal Analysis-Q1 2009 105
8.1.1 Diabetes Care Devices- Deals of Quarter 1 106
8.2 Deal Analysis Q2 2009 106
8.2.1 Diabetes Care Devices – Deals of Quarter 2 107
8.3 Deal Analysis Q3 2009 108
8.3.1 Diabetes Care Devices – Deals of the Quarter 3 109
8.4 Deal Analysis – October 2009 109
8.5 Deal Analysis – December 2009 110

9 Appendix 112
9.1 Decision Support Database 112
9.1.1 Complications with Diabetes 112
9.2 Diabetes Care Devices: Definitions 113
9.2.1 Glucose Monitoring 113
9.2.2 Insulin Delivery 113
9.3 Methodology 113
9.3.1 Secondary Research 114
9.3.2 Primary Research 114
9.3.3 Models 115
9.3.4 Forecasts 115
9.3.5 Expert Panels 115
9.4 Contact Us 115
9.5 Disclaimer 116

1.1 List of Tables
Table 1: Diabetes Mellitus, Estimated Patient Population (‘000′s), 2030 13
Table 2: Diabetes Care Devices, Revenue ($m), Global, 2002 – 2009 14
Table 3: Diabetes Care Devices, Revenue ($m), Global, 2009 – 2016 15
Table 4: Total Cost, Traditional Glucose Meter Vs Continuous Glucose Monitor 16
Table 5: Disposable Insulin Pumps, Revenue ($m), US, 2005 – 2009 19
Table 6: Disposable Insulin Pumps, Revenue ($m), US, 2009 – 2015 20
Table 7: Non Invasive Glucose Monitoring Products 21
Table 8: Pain Free Insulin Delivery Products, 2009 21
Table 9: Prevalence Estimates of Diabetes, Global, 2030 23
Table 10: Prevalence of Diabetes (Diagnosed And Undiagnosed), By Age Group, US, 2007 24
Table 11: Prevalence of Diabetes (Diagnosed And Undiagnosed), By Gender, US, 2007 25
Table 12: Population Over the age of 65 (‘000′s), 2005 – 2010 25
Table 13: Glucose Monitoring, Revenue ($m), Global, 2002 – 2009 29
Table 14: Glucose Monitoring, Revenue ($m), Global, 2009 – 2016 30
Table 15: Blood Glucose Meters, Revenue ($m), Global, 2000 – 2009 32
Table 16: Blood Glucose Meters, Revenue ($m), Global, 2009 – 2016 33
Table 17: Blood Glucose Test Strips, Revenue ($m), Global, 2002 – 2009 34
Table 18: Blood Glucose Test Strips, Revenue ($m), Global, 2009 – 2016 35
Table 19: Comparison of Insulin Delivery Devices 36
Table 20: Insulin Delivery, Revenue ($m), Global, 2002 – 2009 37
Table 21: Insulin Delivery, Revenue ($m), Global, 2009 – 2016 38
Table 22: Insulin Pumps, Revenue ($m), Global, 2002 – 2009 40
Table 23: Insulin Pumps, Revenue ($m), Global, 2009 – 2016 41
Table 24: Insulin Pens, Revenue ($m), Global, 2002 – 2009 43
Table 25: Insulin Pens, Revenue ($m), Global, 2009 – 2016 43
Table 26: Insulin Syringes, Revenue ($m), Global 2002 – 2009 44
Table 27: Insulin Syringes, Revenue ($m), Global 2009 – 2016 45
Table 28: Diabetes Care Devices Market, Revenue ($m), US, 2002 – 2009 55
Table 29: Diabetes Care Devices Market, Revenue ($m), Canada, 2002 – 2009 56
Table 30: Diabetes Care Devices Market, Revenue ($m), UK, 2002 – 2009 57
Table 31: Diabetes Care Devices Market, Revenue ($m), Germany, 2002 – 2009 58
Table 32: Diabetes Care Devices Market, Revenue ($m), France, 2002 – 2009 59
Table 33: Diabetes Care Devices Market, Revenue ($m), Italy, 2002 – 2009 60
Table 34: Diabetes Care Devices Market, Revenue ($m), Spain, 2002 – 2009 61
Table 35: Diabetes Care Devices Market, Revenue ($m), Japan, 2002 – 2009 62
Table 36: Diabetes Care Devices Market, Revenue ($m), China, 2002 – 2009 63
Table 37: Diabetes Care Devices Market, Revenue ($m), India, 2002 – 2009 64
Table 38: Diabetes Care Devices Market, Revenue ($m), Australia, 2002 – 2009 65
Table 39: Diabetes Care Devices Market, Revenue ($m), Brazil, 2002 – 2009 66
Table 40: Diabetes Care Devices Market, Revenue ($m), US, 2009 – 2016 67
Table 41: Diabetes Care Devices Market, Revenue ($m), Canada, 2009 – 2016 68
Table 42: Diabetes Care Devices Market, Revenue ($m), UK, 2009 – 2016 69
Table 43: Diabetes Care Devices Market, Revenue ($m), Germany, 2009 – 2016 70
Table 44: Diabetes Care Devices Market, Revenue ($m), France, 2009 – 2016 71
Table 45: Diabetes Care Devices Market, Revenue ($m), Italy, 2009 – 2016 72
Table 46: Diabetes Care Devices Market, Revenue ($m), Spain, 2009 – 2016 73
Table 47: Diabetes Care Devices Market, Revenue ($m), Japan, 2009 – 2016 74
Table 48: Diabetes Care Devices Market, Revenue ($m), China, 2009 – 2016 75
Table 49: Diabetes Care Devices Market, Revenue ($m), India, 2009 – 2016 76
Table 50: Diabetes Care Devices Market, Revenue ($m), Australia, 2009 – 2016 77
Table 51: Diabetes Care Devices Market, Revenue ($m), Brazil, 2009 – 2016 78
Table 52: Glucose Monitoring Systems Pipeline Product Summary – I 83
Table 53: Glucose Monitoring Systems Pipeline Product Summary – II 84
Table 54: Glucose Monitoring Systems Pipeline Product Summary – III 85
Table 55: Home Glucose Monitoring Systems Pipeline Product Summary – I 87
Table 56: Home Glucose Monitoring Systems Pipeline Product Summary – II 88
Table 57: Hospital Setting Glucose Monitoring System Pipeline Product Summary 89
Table 58: Home and Hospital Setting Glucose Monitoring Systems Pipeline Product Summary 89
Table 59: Glucose Monitoring Systems Emerging Companies and Products- I 91
Table 60: Glucose Monitoring Systems Emerging Companies and Products – II 92
Table 61: Global Insulin Delivery Devices Pipeline Product Summary 96
Table 62: Closed-loop diabetes management system, Product Status 96
Table 63: Closed-loop diabetes management system, Product Description 97
Table 64: Paradigm Veo System, Product Status 97
Table 65: Paradigm Veo System, Product Description 97
Table 66: AERx insulin Diabetes Management System, Product Status 98
Table 67: AERx insulin Diabetes Management System, Product Description 98
Table 68: AERx insulin Diabetes Management System – Effect of Inhaled Insulin (AERx iDMS) Plus Pioglitazone Versus Pioglitazone Alone on HbA1c in Subjects With Type 2 Diabetes 99
Table 69: AERx insulin Diabetes Management System – Inhaled Pre-Prandial Human Insulin With the AERx iDMS Versus s.c. Insulin Aspart in Type 2 Diabetes: A 104 Week, Open-Label, Multicenter, Randomized, Trial Followed by a 12 Week re-Randomized Extension to Investigate Safety and Efficacy 100
Table 70: AERx insulin Diabetes Management System – Inhaled Mealtime Insulin With the AERx iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomized, Parallel Trial (Followed by a Twelve-Week Re-Randomized Extension) To Investigate Safety and Efficacy 101
Table 71: Medical Equipment, Diabetes Care Devices, Deals Summary, Q2 2008 – Q1 2009 105
Table 72: Medical Equipment, Diabetes Care Devices, Deals Summary, Q2 2008 – Q2 2009 107
Table 73: Medical Equipment, Diabetes Care Devices, Deals Summary, Q3 2008 – Q3 2009 108
Table 74: Medical Equipment, Diabetes Care Devices, Deals Summary, April 2009 – September 2009 109
Table 75: Medical Equipment, Diabetes Care Devices, Deals Summary, May 2009 – October 2009 110
Table 76: Medical Equipment, Diabetes Care Devices, Deals Summary, June 2009 – November 2009 111
Table 77: Prevalence of Diabetes (Diagnosed And Undiagnosed), By Age Group, US, 2007 112

1.2 List of Figures
Figure 1: Diabetes Care Devices, Revenue ($m), Global, 2002 – 2009 14
Figure 2: Diabetes Care Devices, Revenue ($m), Global, 2009 – 2016 15
Figure 3: Glucose Monitoring Devices, Distribution Channel Shares (%), 2008 17
Figure 4: Insulin Delivery, Distribution Channel Shares (%), 2008 17
Figure 5: Disposable Insulin Pumps, Revenue ($m), US, 2005 – 2009 19
Figure 6: Disposable Insulin Pumps, Revenue ($m), US, 2009 – 2015 20
Figure 7: Diabetes Incidence by Diagnosis, US, 2007 24
Figure 8: Diabetic Population by Treatment Type, US, 2007 24
Figure 9: Diabetes Care Devices, Company Share (%), Global, 2008 28
Figure 10: Glucose Monitoring, Revenue ($m), Global, 2002 – 2009 29
Figure 11: Glucose Monitoring, Revenue ($m), Global, 2009 – 2016 30
Figure 12: Blood Glucose Meters, Revenue ($m), Global, 2000 – 2009 32
Figure 13: Blood Glucose Meters, Revenue ($m), Global, 2009 – 2016 33
Figure 14: Blood Glucose Test Strips, Revenue ($m), Global, 2002 – 2009 34
Figure 15: Blood Glucose Test Strips, Revenue ($m), Global, 2009 – 2016 35
Figure 16: Insulin Delivery, Revenue ($m), Global, 2002 – 2009 37
Figure 17: Insulin Delivery, Revenue ($m), Global, 2009 – 2016 38
Figure 18: Insulin Pumps, Revenue ($m), Global, 2002 – 2009 40
Figure 19: Insulin Pumps, Revenue ($m), Global, 2009 – 2016 41
Figure 20: Insulin Pens, Revenue ($m), Global, 2002 – 2009 42
Figure 21: Insulin Pens, Revenue ($m), Global, 2009 – 2016 43
Figure 22: Insulin Syringes, Revenue ($m), Global 2002 – 2009 44
Figure 23: Insulin Syringes, Revenue ($m), Global 2009 – 2016 45
Figure 24: Strategic Competitive Assessment 46
Figure 25: Insulin Delivery Devices, Company Share Analysis (%), 2008 47
Figure 26: Glucose Monitoring, Strategic Competitive Assessment 49
Figure 27: Glucose Monitoring Systems, Company Shares – 2008 50
Figure 28: Diabetes Care Devices Market, Revenue ($m), US, 2002 – 2009 55
Figure 29: Diabetes Care Devices Market, Revenue ($m), Canada, 2002 – 2009 56
Figure 30: Diabetes Care Devices Market, Revenue ($m), UK, 2002 – 2009 57
Figure 31: Diabetes Care Devices Market, Revenue ($m), Germany, 2002 – 2009 58
Figure 32: Diabetes Care Devices Market, Revenue ($m), France, 2002 – 2009 59
Figure 33: Diabetes Care Devices Market, Revenue ($m), Italy, 2002 – 2009 60
Figure 34: Diabetes Care Devices Market, Revenue ($m), Spain, 2002 – 2009 61
Figure 35: Diabetes Care Devices Market, Revenue ($m), Japan, 2002 – 2009 62
Figure 36: Diabetes Care Devices Market, Revenue ($m), China, 2002 – 2009 63
Figure 37: Diabetes Care Devices Market, Revenue ($m), India, 2002 – 2009 64
Figure 38: Diabetes Care Devices Market, Revenue ($m), Australia, 2002 – 2009 65
Figure 39: Diabetes Care Devices Market, Revenue ($m), Brazil, 2002 – 2009 66
Figure 40: Diabetes Care Devices Market, Revenue ($m), US, 2009 – 2016 67
Figure 41: Diabetes Care Devices Market, Revenue ($m), Canada, 2009 – 2016 68
Figure 42: Diabetes Care Devices Market, Revenue ($m), UK, 2009 – 2016 69
Figure 43: Diabetes Care 0044evices Market, Revenue ($m), Germany, 2009 – 2016 70
Figure 44: Diabetes Care Devices Market, Revenue ($m), France, 2009 – 2016 71
Figure 45: Diabetes Care Devices Market, Revenue ($m), Italy, 2009 – 2016 72
Figure 46: Diabetes Care Devices Market, Revenue ($m), Spain, 2009 – 2016 73
Figure 47: Diabetes Care Devices Market, Revenue ($m), Japan, 2009 – 2016 74
Figure 48: Diabetes Care Devices Market, Revenue ($m), China, 2009 – 2016 75
Figure 49: Diabetes Care Devices Market, Revenue ($m), India, 2009 – 2016 76
Figure 50: Diabetes Care Devices Market, Revenue ($m), Australia, 2009 – 2016 77
Figure 51: Diabetes Care Devices Market, Revenue ($m), Brazil, 2009 – 2016 78
Figure 52: Technology Trends Analytic Framework 79
Figure 53: Glucose Monitoring Systems – Pipeline by Clinical Phase of Development 80
Figure 54: Glucose Monitoring Systems Pipeline Product by Product Type 86
Figure 55: Strategic Competitor Assessment 90
Figure 56: Technology Trends Analytic Framework 93
Figure 57: Technology Trends Analytic Framework – Descriptions 94
Figure 58: Insulin Delivery Devices – Clinical Pipeline by Mode of Insulin Delivery 94
Figure 59: Insulin Delivery Devices Pipeline by Clinical Phase of Development 95
Figure 60: Strategic Competitor Assessment 102
Figure 61: Reimbursement for Insulin Delivery Devices 103
Figure 62: Reimbursement Mix – Insulin Pens 104
Figure 63: Medical Equipment, Diabetes Care Devices, Deal Value and Volume, Q2 2008 – Q1 2009 105
Figure 64: Medical Equipment, Diabetes Care Devices, Deal Value and Volume, Q2 2008 – Q2 2009 106
Figure 65: Medical Equipment, Diabetes Care Devices, Deal Value and No. Of Deals, Q3 2008 – Q3 2009 108
Figure 66: Diabetes Incidence by Diagnosis, US, 2007 112
Figure 67: Diabetic Population by Treatment Type, US, 2007 112
Figure 68: GBI Research Methodology 114

The Future of the Diabetes Care Devices Market to 2016 – The Key Demand Drivers Remain Intact now Available on ReportsandReports. ReportsandReports, comprising of an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites.

New Generation REMOTE CONTROL DOG 6 LEVEL STATIC Multi-function training device

US $38.99
End Date: Wednesday Feb-22-2012 21:17:42 PST
Buy It Now for only: US $38.99
Buy it now | Add to watch list

Posted in COMPUTING & INTERNETComments (0)

Tag Archive | "Care"

Newborn Care Questions- Can Bring An End To Those Apprehensions

Safetox – an Anti Ageing Skin Care Device to Look Younger and Radiant

Kids health care plans on hold in Missouri

Kids health care plans on hold in Missouri

The Future Of The Diabetes Care Devices Market To 2016 – The Key Demand Drivers Remain Intact

Popularity Contest

Recent Comments